Chemical and functional changes of human insulin by in vitro incubation with blood from diabetic patients in oxidative stress

Metabolism: Clinical and Experimental

Volumn 59, Issue 7, 2010, Pages 935-942

  Montes Cortes, Daniel H ^a   Hicks, Juan J ^b   Ceballos Reyes, Guillermo M ^c   Garcia Sanchez, Jose R ^c   Medina Navarro, Rafael ^d   Olivares Corichi, Ivonne M ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c School of Medicine National Polytechnique Institute   (Mexico)

^d Mexico   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; DITYROSINE DERIVATIVE; FORMAZAN; ORGANONITROGEN DERIVATIVE; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; CHEMICAL REACTION; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN METABOLISM; INTERMETHOD COMPARISON; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FORMAZANS; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; INSULIN; IRON; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 77952942473     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.10.013     Document Type: Article

References (45)

1. Sohal R.S., Mockett R.J., and Orr W.C. Mechanism of aging: an appraisal of the oxidative stress hypothesis. Free Radic Biol Med 33 (2002) 575-586
2. Kumar B., Koul S., Khandrika L., et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 68 (2008) 1777-1785
3. Higashi Y., Jitsuiki D., and Chayama K. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Patents Cardiovasc Drug Discov 1 (2006) 85-93
4. Hsiai T., and Berliner J.A. Oxidative stress as a regulator of murine atherosclerosis. Curr Drug Targets 8 (2007) 1222-1229
5. Papaiahgari S., Yerrapureddy A., and Reddy S.R. Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice. Am J Respir Crit Care Med 176 (2007) 1222-1235
6. Ban J.Y., Cho S.O., and Choi S.H. Neuroprotective effect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo. J Pharmacol Sci 106 (2008) 68-77
7. Zhu X., Su B., and Wang X. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64 (2007) 2202-2210
8. Vincent H.K., Bourguignon C.M., Weltman A.L., et al. Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism 58 (2009) 254-262
9. Rahangdale S., Yeh S.Y., Malhotra A., et al. Therapeutic interventions and oxidative stress in diabetes. Front Biosci 14 (2009) 192-209
10. Duncan E., Ezzat V., and Kearney M. Insulin and endothelial function: physiological environment defines effect on atherosclerotic risk. Curr Diabetes Rev 2 (2006) 51-61
11. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?. Cardiovasc Res 47 (2000) 410-418
12. Lopes J.P., Oliveira S.M., and Soares Fortunato J. Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications. Acta Med Port 21 (2008) 293-302
13. Gupta A., Tripathi A.K., and Tripathi R.L. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys 44 (2007) 373-378
14. Hunter S.J., Boyd A.C., O'Harte F.P., et al. Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans. Diabetes 52 (2003) 492-498
15. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
16. Desco M.C., Asensi M., Márquez R., et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51 (2002) 1118-1124
17. Rabbani N., and Thornalley P.J. Quantitation of markers of protein damage by glycation, oxidation, and nitration in peritoneal dialysis. Perit Dial Int 29 (2009) S51-S56
18. Bakhti M., Habibi-Rezaei M., Moosavi-Movahedi A.A., et al. Consequential alterations in haemoglobin structure upon glycation with fructose: prevention by acetylsalicylic acid. J Biochem 141 (2007) 827-833
19. Wu C.H., Lin J.A., Hsieh W.C., et al. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro. J Agric Food Chem 57 (2009) 5058-5064
20. Olivares-Corichi I.M., Ceballos G., and Ortega-Camarillo C. Reactive oxygen species (ROS) induce chemical and structural changes on human insulin in vitro, including alterations in its immunoreactivity. Front Biosci 10 (2005) 838-843
21. 14 utilization by human adipose tissue. Front Biosci 10 (2005) 3127-3131
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care Suppl 1 (2008) S55-S60
23. Yagi K. Sample procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 108 (1998) 107-110
24. Gieseg S.P., Simpson J.A., Charlton T.S., et al. Protein-bound 3,4 dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32 (1993) 4780-4786
25. Heinecke J.W., Li W., Daehnke III H.L., et al. Dityrosine, a specific marker of oxidation, is synthesized the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 268 (1993) 4069-4077
26. Malencik D.A., Sprouse J.F., Swanson C.A., et al. Dityrosine: preparation, Isolation, and Analysis. Anal Biochem 242 (1996) 202-213
27. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233 (1994) 357-363
28. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
29. Rizvi S.I., and Zaid M.A. Intracellular reduced glutathione content in normal and type 2 diabetic erythrocytes: effect of insulin and (-)epicathechin. J Physiol Pharmacol 52 (2001) 483-488
30. Leo R., Praticò D., Iuliano L., et al. Platelet activation by superoxide anion and hydroxyl radical intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation 95 (1997) 885-891
31. Firoozrai M., Nourbakhsh M., and Razzaghy-Azar M. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res Clin Pract 77 (2007) 427-432
32. Rysz J., Błaszczak R., Banach M., et al. Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation. Arch Immunol Ther Exp (Warsz) 55 (2007) 335-340
33. Mirmira R.G., Nakagawa S.H., and Tager H.S. Importance of the character and configuration of residues B24, B25, and B26 in insulin receptor interactions. J Biol Chem 266 (1991) 1428-1436
34. Xu B., Hu S.Q., Chu Y.C., Wang S., Wang R.Y., Nakagawa S.H., et al. Diabetes associated mutations in insulin identify invariant receptor contact. Diabetes 53 (2004) 1599-1602
35. Shoelson S., Haneda M., Blix P., Nanjo A., Sanke T., Inouye K., et al. Three mutant insulins in man. Nature 302 (1983) 540-543
36. Steiner D.F., Tager H.S., Chan S.J., Nanjo K., Sanke T., and Rubenstein A.H. Lesson learned from molecular biology of insulin-gene mutation. Diabetes Care 13 (1990) 600-609
37. Dalle-Donne I., Rossi R., Giustarini D., et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329 (2003) 23-38
38. Amici A., Levine R.L., and Stadtman E.R. Conversion of amino acids residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed reactions. J Biol Chem 264 (1989) 3341-3346
39. Uchida K., Kato Y., and Kawakishi S. A novel mechanism for oxidative cleavage of prolyl peptides induced by hydroxyl radicals. Biochem Biophys Res Commun 169 (1990) 265-271
40. Medina-Navarro R., Guzmán-Grenfell A.M., Díaz-Flores M., et al. Formation of an adduct between insulin and the toxic lipoperoxidation product acrolein decreases both the hypoglycemic effect of the hormone in rat and glucose uptake in 3T3 adipocytes. Chem Res Toxicol 20 (2007) 477-1481
41. Voziyan P.A., Metz T.O., Baynes J.W., et al. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 277 (2002) 3397-3403
42. Friguet B., Stadtman E.R., and Szweda L.I. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal: formation of cross-linked protein which inhibits the multicatalytic protease. J Biol Chem 269 (1994) 21639-21643
43. Miyata T. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress"). Bull Mem Acad R Med Belg 157 (2002) 189-196
44. Chetyrkin S.V., Mathis M.E., Ham A.J., et al. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine. Free Radic Biol Med 44 (2008) 1276-1285
45. Amarnath V., Amarnath K., Amarnath K., et al. Pyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls. Chem Res Toxicol 17 (2004) 410-415